Apimeds Pharmaceuticals US, Inc. (APUS)

Apimeds Pharmaceuticals US, Inc. began as a biopharmaceutical company developing Apitox, a bee venom-based injectable therapy for knee osteoarthritis pain. Development of that program continues in collaboration with Lokahi Therapeutics.

The company has since shifted much of its focus to digital assets. Through its MindWave Innovations subsidiary, it operates a bitcoin treasury strategy and develops blockchain infrastructure and platforms for partners. Apimeds is based in Matawan, New Jersey, and its common stock trades on NYSE American.